Teladoc Health (NYSE:TDOC) Price Target Raised to $12.00

Teladoc Health (NYSE:TDOC - Free Report) had its target price raised by Deutsche Bank Aktiengesellschaft from $10.00 to $12.00 in a research report sent to investors on Friday morning, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a hold rating on the health services provider's stock.

Several other equities research analysts have also weighed in on the stock. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $25.00 to $17.00 and set a "buy" rating on the stock in a report on Thursday, August 1st. Stifel Nicolaus decreased their price objective on shares of Teladoc Health from $16.00 to $9.00 and set a "hold" rating on the stock in a research note on Thursday, August 1st. Piper Sandler cut their target price on shares of Teladoc Health from $25.00 to $10.00 and set an "overweight" rating for the company in a research note on Tuesday, August 6th. Truist Financial decreased their price target on Teladoc Health from $15.00 to $10.00 and set a "hold" rating on the stock in a research report on Friday, August 2nd. Finally, Barclays raised their price target on Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a report on Thursday. Fourteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $11.97.

Teladoc Health Stock Performance

Shares of Teladoc Health stock traded up $0.21 during trading on Friday, reaching $9.22. The company's stock had a trading volume of 6,591,671 shares, compared to its average volume of 5,475,505. The business's fifty day moving average price is $8.48 and its 200-day moving average price is $9.69. Teladoc Health has a one year low of $6.76 and a one year high of $22.54. The firm has a market cap of $1.58 billion, a price-to-earnings ratio of -1.60 and a beta of 0.91. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to analysts' expectations of $630.50 million. Teladoc Health had a negative return on equity of 9.40% and a negative net margin of 37.91%. As a group, equities research analysts predict that Teladoc Health will post -1.18 earnings per share for the current year.

Insider Buying and Selling at Teladoc Health

In related news, Director Thomas Mckinley bought 7,000 shares of Teladoc Health stock in a transaction that occurred on Tuesday, August 6th. The stock was purchased at an average cost of $7.57 per share, with a total value of $52,990.00. Following the purchase, the director now owns 31,077 shares in the company, valued at approximately $235,252.89. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, COO Michael Willem Waters sold 4,218 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $30,200.88. Following the completion of the transaction, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Thomas Mckinley bought 7,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 6th. The stock was acquired at an average cost of $7.57 per share, with a total value of $52,990.00. Following the transaction, the director now owns 31,077 shares of the company's stock, valued at $235,252.89. This represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 36,588 shares of company stock valued at $268,831. 0.95% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently made changes to their positions in the stock. Clearline Capital LP grew its holdings in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock worth $42,682,000 after purchasing an additional 3,483,665 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of Teladoc Health by 195.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock worth $932,000 after acquiring an additional 63,028 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Teladoc Health by 74.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider's stock worth $311,000 after acquiring an additional 8,750 shares during the last quarter. Mackenzie Financial Corp raised its stake in Teladoc Health by 170.7% in the 2nd quarter. Mackenzie Financial Corp now owns 107,255 shares of the health services provider's stock valued at $1,049,000 after acquiring an additional 67,640 shares during the period. Finally, Janney Montgomery Scott LLC raised its stake in Teladoc Health by 188.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider's stock valued at $477,000 after acquiring an additional 20,651 shares during the period. Institutional investors and hedge funds own 76.82% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.